Clinical Trial Detail

NCT ID NCT04154956
Title SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients (CARMEN-LC03)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sanofi
Indications

lung non-squamous non-small cell carcinoma

Therapies

SAR408701

Docetaxel

Age Groups: adult senior

No variant requirements are available.